Finance

Lists
Outlook: 76.5% bullish·0.0% bearish
Go to analysis
AVAH:NASDAQ
Aveanna Healthcare Holdings Inc
$11.67
+0.34%
(+0.040) 1D
Nov 17, 3:28:50 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AVAH...
Open
$11.63
High
$12.04
Low
$11.57
Mkt. cap
2.55B
Avg. vol.
2.30M
Volume
1.84M
P/E ratio
8.57
52-wk high
$14.71
52-wk low
$5.93
EPS
$1.36
Beta
2.03
Shares outstanding
218.41M
No. of employees
20K
Open
$11.63
High
$12.04
Low
$11.57
Mkt. cap
2.55B
Avg. vol.
2.30M
Volume
1.84M
P/E ratio
8.57
52-wk high
$14.71
52-wk low
$5.93
EPS
$1.36
Beta
2.03
Shares outstanding
218.41M
No. of employees
20K
News stories
From web sources and news partners
About Aveanna Healthcare Holdings Inc
CEO-
Employees19.5K
Founded2016
HeadquartersAtlanta, Georgia, United States
SectorHealth Care
IndustryHealth care provider
Analyst ratings
Based on 7 analysts giving stock ratings to AVAH in the past 3 months
Buy
Buy
4
Hold
3
Sell
0
12-month forecast
Based on 7 Wall Street analysts offering 12 month price targets for AVAH in the last 3 months.
Highest
Current $11.67
$16.00 (+37.10%)
Average
$15.00 (+28.53%)
Lowest
$13.00 (+11.40%)
Analyst
Recommendation
Action
Price target
Projected
Date
Unknown Analyst
UBS
Hold
Maintained
$13.00
+11.4%
11/16/2026
Andrew Mok CFA
Barclays
Buy
Maintained
$15.00
+28.5%
11/13/2026
Sean Dodge
BMO Capital
Buy
Reiterated
$16.00
+37.1%
11/13/2026
Ben Hendrix
RBC Capital
Buy
Reiterated
$16.00
+37.1%
11/12/2026
Andrew Cooper
Raymond James
Buy
Maintained
$15.00
+28.5%
09/28/2026
Benjamin Rossi
J.P. Morgan
Hold
Reiterated
$15.00
+28.5%
09/14/2026
David S Macdonald
Truist Financial
Hold
Maintained
$15.00
+28.5%
08/24/2026
Unknown Analyst
Deutsche Bank
Buy
Maintained
$16.00
+37.1%
08/14/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
08/13/2026
Srikripa Devarakonda
Truist Financial
Hold
Reiterated
-
-
06/08/2026
Unknown Analyst
Stephens
Buy
Upgraded
$11.00
-5.7%
05/15/2026
Raj Kumar CFA
Stephens
Buy
Upgraded
$11.00
-5.7%
05/15/2026
John Ransom
Raymond James
Buy
Maintained
$13.00
+11.4%
03/20/2026
Brian Tanquilut
Jefferies
Buy
Maintained
$10.00
-14.3%
03/20/2026
Last report
Nov 12, 2026
Fiscal period
Q3 2026
$0.23 / $0.21
+10.90%beat
Revenue / Est. (USD)
695.54M / 680.62M
+2.19%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Jan 2026
Apr 2026
Jul 2026
Oct 2026
Revenue
662.48M
647.92M
670.48M
695.54M
Cost of goods sold
455.38M
442.49M
451.96M
468.78M
Cost of revenue
455.38M
442.49M
451.96M
468.78M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
113.97M
129.95M
131.16M
139.38M
Operating expense
115.91M
132.99M
134.16M
142.54M
Total operating expenses
571.29M
575.48M
586.11M
611.32M
Operating income
91.19M
72.44M
84.37M
84.22M
Other non operating income
3.68M
4.99M
5.02M
7.94M
EBT including unusual items
39.24M
44.98M
56.47M
64.78M
EBT excluding unusual items
61.26M
48.08M
60.86M
65.44M
Income tax expense
-139.51M
3.32M
16.18M
19.33M
Effective tax rate
-355.48%
7.39%
28.65%
29.83%
Other operating expenses
-788.00K
-
144.00K
-
Net income
178.75M
41.65M
40.29M
45.45M
Net profit margin
26.98%
6.43%
6.01%
6.53%
Earnings per share
0.17
0.18
0.22
0.23
Interest and investment income
1.74M
1.66M
1.26M
370.00K
Interest expense
-35.35M
-31.00M
-29.79M
-27.08M
Net interest expenses
-33.61M
-29.34M
-28.53M
-26.72M
Depreciation and amortization charges
2.73M
3.04M
2.85M
3.16M
EBITDA
93.52M
75.48M
87.22M
87.39M
Gain or loss from assets sale
1.14M
-24.00K
144.00K
131.00K
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google apps